Biovica International AB Income Statement

Financials in millions SEK. Fiscal year is May - April.

Millions SEK. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 31, 2025	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Operating Revenue	9.86	8.62	7.29	4.96	5.04	5.64
Other Revenue	0.03	0.03	0.01	0.26	0.06	1.84
Revenue	9.89	8.65	7.3	5.21	5.1	7.48
Revenue Growth (YoY)	41.22%	18.53%	39.99%	2.22%	-31.85%	-22.71%
Cost of Revenue	-0.1	0.54	0.41	0.34	0.37	0.37
Gross Profit	9.99	8.11	6.88	4.87	4.73	7.11
Selling, General & Admin	78.08	85.63	123.52	106.69	59.35	42.55
Other Operating Expenses	1.4	1.78	1.56	0.9	-0.84	-1.17
Operating Expenses	88.09	96.25	134.51	115.8	64.95	47.52
Operating Income	-78.11	-88.14	-127.63	-110.92	-60.22	-40.41
Interest Expense	-	-0.22	-0.29	-0.28	-0.08	-0.06
Interest & Investment Income	1.36	1	1.16	0.27	-	0.86
Currency Exchange Gain (Loss)	1.38	1.38	2.63	0.17	0.25	0.23
Other Non Operating Income (Expenses)	-1.02	-	-	0	-	-0
EBT Excluding Unusual Items	-76.38	-85.98	-124.14	-110.76	-60.04	-39.39
Gain (Loss) on Sale of Assets	-	-	-	0.08	0.05	0
Pretax Income	-76.38	-85.98	-124.14	-110.68	-59.99	-39.39
Income Tax Expense	0.09	1.64	0.69	-0.19	0.01	0.1
Net Income	-76.47	-87.62	-124.82	-110.49	-60	-39.48
Net Income to Common	-76.47	-87.62	-124.82	-110.49	-60	-39.48
Shares Outstanding (Basic)	138	93	58	35	28	28
Shares Outstanding (Diluted)	138	93	58	35	28	28
Shares Change (YoY)	74.32%	58.49%	67.70%	22.40%	0.17%	20.50%
EPS (Basic)	-0.55	-0.95	-2.14	-3.17	-2.11	-1.39
EPS (Diluted)	-0.55	-0.95	-2.14	-3.17	-2.11	-1.39
Free Cash Flow	-71.01	-85.65	-114.72	-95.85	-52.53	-34.41
Free Cash Flow Per Share	-0.51	-0.93	-1.96	-2.75	-1.85	-1.21
Gross Margin	100.96%	93.81%	94.34%	93.47%	92.72%	95.09%
Operating Margin	-789.66%	-1019.33%	-1749.57%	-2128.65%	-1181.21%	-540.24%
Profit Margin	-773.12%	-1013.35%	-1711.08%	-2120.36%	-1176.99%	-527.85%
Free Cash Flow Margin	-717.94%	-990.56%	-1572.60%	-1839.30%	-1030.44%	-460.01%
EBITDA	-77.25	-87.06	-126.55	-109.71	-59.01	-38.9
D&A For EBITDA	0.85	1.08	1.08	1.22	1.21	1.51
EBIT	-78.11	-88.14	-127.63	-110.92	-60.22	-40.41
Revenue as Reported	11.19	10.96	8.3	5.7	6.3	8.88

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.